Alkixen 250 Mg (Crizotinib) – 60 Capsules

Alkixen 250 Mg (Crizotinib) works for treating patients with locally advanced or metastatic non-small cell lung cancer (NSCLC) that is anaplastic lymphoma kinase (ALK)-positive or ROS 1 positive. Alkixen is a doctor prescription (Crizotinib) medicine.

Alkixen 250 mg is indicated for:

• ALK-Positive Non-Small Cell Lung Cancer (NSCLC): Alkixen is used as a first-line treatment for patients with advanced or metastatic ALK-positive NSCLC. It offers a targeted therapy option that directly addresses the underlying genetic abnormality driving the cancer.
• ROS1-Positive NSCLC: Alkixen 250 Mg is also approved for the treatment of patients with ROS1-positive metastatic NSCLC, another genetic alteration that Crizotinib effectively targets.
• Post-Chemotherapy Therapy: Alkixen may be used in patients who have progressed on or are intolerant to standard chemotherapy, providing an alternative treatment pathway for those with resistant or recurrent disease.

Everest Pharma Ltd. manufacture Alkixen. Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Alkixen 250 Mg tablet may be taken with or without food, but it is better to take it at a fixed time.

⭐️⭐️⭐️⭐️⭐️

Product Feature:

Essential medications for Lung Cancer, such as Alkixen 250 Mg (Crizotinib), can be procured from Unit Pharmacy!